Question explored with the scientific record
Conversation so far
- 1 Does preganalin withdrawal give you night terrors + a private exchange
- 2 Are there safer alternatives for sleep during pregabalin tapering? + a private exchange
- 3 What taper rate is safest to reduce withdrawal insomnia? + a private exchange
- 4 Could this be from withdrawal vs something else like sleep apnea or PTSD?
Answered on this page ↓
Could this be from withdrawal vs something else like sleep apnea or PTSD?
The short version: withdrawal is the best-supported explanation for the dreams, but nothing in these records ties pregabalin withdrawal to nightmares or violence, and sleep apnea and PTSD are not ruled out.
The pregabalin withdrawal record is real but narrow. Three people without psychiatric history got anxiety, restlessness, insomnia and, in one case, suicidal ideation after a cut, and symptoms eased when the drug was resumed [1]. A 2024 commentary warns psychiatric symptoms can follow sudden withdrawal even at standard doses [2]. Neither names nightmares or violence. The one severe case on record is a 24-year-old on 4200 mg/day who stopped cold and had a seizure on day three, with normal labs, MRI and EEG [3]. That is a high-dose dependence case, not yours.
Sleep apnea is a genuine alternative. The records show OSA is tied to fragmented sleep, nocturnal hypoxemia and arousals [4], and hypoxemia during sleep is linked to worse outcomes [5]. None of these records measure nightmares or violent behavior in OSA. PTSD is the weakest fit on the evidence here: the PTSD records are about brain imaging, autoimmune risk and treatment, not sleep violence [6][7][8]. Nothing in this retrieval compares withdrawal versus apnea versus PTSD head to head.
| Cause | What the records show | Gap for your question |
|---|---|---|
| Pregabalin withdrawal | Anxiety, insomnia, suicidal ideation after cut [1][2] | No nightmares, no violence |
| Sleep apnea | Fragmented sleep, hypoxemia, arousals [4][5] | No nightmare or violence data |
| PTSD | Imaging, autoimmune, treatment studies [6][7] | No sleep-violence data |
My call: treat withdrawal as the leading hypothesis given the taper timing, but get a sleep study and a trauma history before you assume it, because the records cannot separate these three. Confidence: low, because no study here measured nightmares or violence against any of these causes.
Sources used 8
-
Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review
Three patients without psychiatric or substance-use disorders developed withdrawal symptoms after abrupt reduction or discontinuation of regular-dose pregabalin, and symptoms improved after resuming pregabalin; a literature review found six similar published cases.
DOI: 10.1002/npr2.12195 -
Psychiatric Symptoms Following Sudden Withdrawal from the Drug Pregabalin
Doctors and pharmacy staff should be aware that psychiatric symptoms may occur after sudden withdrawal from pregabalin, even in standard-dose patients; doses should be tapered rather than stopped suddenly.
DOI: 10.23937/2474-3631/1510044 -
SEİZURE TRİGGERED BY SUDDEN DİSCONTİNUATİON OF PREGABALİN: A CASE REPORT
A 24-year-old male with pregabalin dependence and no history of epilepsy developed a generalized tonic-clonic seizure three days after abruptly discontinuing chronic high-dose (4200 mg/day) pregabalin, with all investigations (labs, MRI, EEG) normal, and no seizure recurrence af…
DOI: 10.70846/nigdetip.1813909 -
Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality
A large retrospective analysis of adults with moderate-to-severe obstructive sleep apnea finds that cardiometabolic comorbidities are tied to greater OSA severity, worse nocturnal oxygenation, and poorer sleep quality, with specific polysomnographic patterns predicting diabetes,…
DOI: 10.1186/s12931-020-1284-7 -
Sleep Apnea-Related Hypoxemia Predicts Post-Stroke Disability Better Than Apnea-Hypopnea Index
ODI and nocturnal hypoxemia duration independently predict 3-month post-stroke disability, outperforming apnea-hypopnea index as a prognostic marker in acute ischemic stroke patients.
DOI: 10.17241/smr.2025.02845 -
Posterior and prefrontal contributions to the development posttraumatic stress disorder symptom severity: an fMRI study of symptom provocation in acute stress disorder
This study investigates the neural correlates of symptom provocation in acute stress disorder (ASD) and their predictive value for subsequent posttraumatic stress disorder (PTSD) symptom severity using fMRI.
DOI: 10.1007/s00406-016-0713-6 -
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder
This study investigates the elevated risk of autoimmune disorders in Iraq and Afghanistan veterans diagnosed with posttraumatic stress disorder (PTSD), revealing that PTSD significantly increases the risk for various autoimmune conditions compared to veterans without psychiatric…
DOI: 10.1016/j.biopsych.2014.06.015 -
Prevention of posttraumatic stress disorder with propranolol: A meta-analytic review
This meta-analytic review investigates the effectiveness of propranolol in preventing posttraumatic stress disorder (PTSD) following traumatic events, concluding that it does not significantly alter PTSD incidence.
DOI: 10.1016/j.jpsychores.2015.04.006